Indices | Comparison group (n = 93) | Study group (n = 157) | Control group (n = 50) |
---|---|---|---|
Ig M g/l | 1.68 (1.36-2.00) | 1.92*(1.44-2.40) | 1.21 (0.98-1.44) |
Ig G g/l | 12.1 (9.74-14.46) | 12.98 (11.10-14.86) | 12.3(10.60-15.11) |
Circulating immune complexes,conventional units of optical density(explain shortcuts) | 79.0 (38.5-109.5) | 105.5* (81.6-129.4) | 65.0 (44.0-67.0) |
Phagocytic number % | 88.0 (82.0 92.0) | 92.0 (90.0-94.0) | 89.0 (84.0- 90.0) |
Phagocytizing neutrophils, st.un | 4.4 (3.3-4.6) | 4.3 (4.2- 4.7) | 3.9 (3.3-4.4) |
Bactericidal activity of neutrophils, % | 37.7 (35.4-38.8) | 39.9 (39.0-40.9) | 37.7 (36.4-38.9) |
Index of phagocytosis completeness, st. un.>1.0 | 0.94 (0.85- 0.99) | 0.84*(0.72-0.93) | 1.15 (0.98-1.4) |
Indices | Comparison group (n=93) | Study group (n= ..157.) | Control group (n=50) |
---|---|---|---|
Т-total lymphocytes – (CD3+) (%) | 72.4 (65.8-77.2) | 68.8 (58.2-77.0) | 75.5 (70.5-78.4) |
Т-helpers/inducers- (CD3+/CD4+) (%) | 40.8 (35.9-50.8) | 32.3* (30.3-38.7) | 47.2 (39.4-53.8) |
Т-supressors/cytotoxic (CD3+/CD8+ ) (%) | 22.2 (18.3-33.0) | 20.8 (16.5-33.6) | 24.3 (23.5-32.5) |
В –lymphocytes (СD19+) (%) | 10.0 (7.7-14.7) | 10.8 (7.0-13.0) | 10.5 (9.7-13.5) |
ТNK-lymphocytes |
7.6* (4.0-11.0) | 9.8* (6.7-12.1) | 5.5 (4.5-6.3) |
NK –lymphocytes (CD3- CD16+/CD56+) ( %) | 3.9 (2.6-7.5) | 4.3 (3.1-7.7) | 4.0 (2.5-7.4) |
Т-activated lymphocytes |
3.9 (2.6-7.5) | 4.3 (3.1-7.7) | 4.0 (2.5-7.4) |
IL-1β pg/ml | 18.8(9.8-20.3) | 31.6* (24.1-42.6) | 6.2 (0-8.5) |
IL-6, pg/ml | 12.4* (9.3-16.3) | 20.6*(17.2-24.1) | 5.2 (0 - 8.2) |
IL-10, pg/ml | 10.8 (9.6-15.5) | 4.2*(0.1-5.0) | 15.5(12.5-20.5) |
TNFα pg/ml | 56.1 (52.2-61.3) | 70.8*(61.6-72.7) | 34.6(28.1-42.4) |